Division of Nephrology, University of Virginia Health System, Charlottesville, VA; and Division of Endocrinology and Metabolism, University of Virginia Health System, Charlottesville, VA.
Division of Nephrology, University of Virginia Health System, Charlottesville, VA; and Division of Endocrinology and Metabolism, University of Virginia Health System, Charlottesville, VA.
Adv Chronic Kidney Dis. 2014 Jan;21(1):7-17. doi: 10.1053/j.ackd.2013.05.005.
Patients with malignancies commonly experience abnormalities in serum electrolytes, including hyponatremia, hypokalemia, hyperkalemia, hypophosphatemia, and hypercalcemia. In many cases, the causes of these electolyte disturbances are due to common etiologies not unique to the underlying cancer. However, at other times, these electrolyte disorders signal the presence of paraneoplastic processes and portend a poor prognosis. Furthermore, the development of these electrolyte abnormalities may be associated with symptoms that can negatively affect quality of life and may prevent certain chemotherapeutic regimens. Thus, prompt recognition of these disorders and corrective therapy is critical in the care of the patient with cancer.
患有恶性肿瘤的患者通常会出现血清电解质异常,包括低钠血症、低钾血症、高钾血症、低磷血症和高钙血症。在许多情况下,这些电解质紊乱的原因并非癌症特有的常见病因。然而,在其他时候,这些电解质紊乱提示存在副肿瘤过程,并预示预后不良。此外,这些电解质异常的发展可能与会对生活质量产生负面影响的症状有关,并且可能会阻止某些化疗方案的实施。因此,及时识别这些疾病并进行纠正治疗对癌症患者的护理至关重要。